PREETI SRIVASTAVA: Open Payments
NPI 1043806516 · FRANKLIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,721 in 214 payments from 18 companies in 2025. Trend: 2023 $2,592 · 2024 $2,456 · 2025 $3,721
Food & beverage: $3,721
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 17 | $505 |
| E.R. Squibb & Sons, L.L.C. | 16 | $444 |
| Supernus Pharmaceuticals, Inc. | 41 | $347 |
| Alkermes, Inc. | 17 | $293 |
| Otsuka America Pharmaceutical, Inc. | 16 | $293 |
| Neurocrine BioSciences, Inc. | 10 | $281 |
| Janssen Pharmaceuticals, Inc | 12 | $215 |
| Axsome Therapeutics, Inc. | 9 | $211 |
| Teva Pharmaceuticals USA, Inc. | 12 | $205 |
| ABBVIE INC. | 21 | $200 |
Products named: COBENFY, Qelbree, REXULTI, INGREZZA, FANAPT, HETLIOZ, ARISTADA, Auvelity.
Industry payments across TN — which companies pay providers there.
